PMH47 USE AND COST OF POLYPHARMACY IN SCHIZOPHRENIA: DATA FROM A RANDOMIZED, DOUBLE-BLIND STUDY OF RISPERIDONE AND QUETIAPINE
Authors:
- Mf RupnowMRMf Rupnow
- A GreenspanAGA Greenspan
- C Kosik-GonzalezCKC Kosik-Gonzalez
- Y ZhuYZY Zhu
- G GharabawiGGG Gharabawi
- Sm StahlSSSm Stahl
- 30 June 2005
- journal article
- abstracts
- Published by Elsevier in Value in Health
- Vol. 8 (3) , 399